About Bright Path Labs
Bright Path Labs is a Healthcare company based in Santa Fe (United States) founded in 2019. It operates as a spinning tube-in-tube continuous-flow reactors are developed for drug manufacturing. Bright Path Labs offers products and services including Manufacturing Services and Research and Development. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its legal entity is Bright Path Laboratories. Its competitors include Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Bright Path Labs was founded in 2019 and is based in Santa Fe, United States. Operations focus on pharmaceutical manufacturing technology, where spinning tube-in-tube (STT) continuous-flow reactors have been developed for drug production. These reactors are applied to scale up manufacturing processes for Covid-19 therapeutics and active pharmaceutical ingredients (APIs). The domain brightpathlabs.com is utilized for online presence.
- Headquarters Santa Fe, United States
- SectorsHealthcare
- Phone•••• ••••
- Website brightpathlabs.com
- Social LinkedIn X
- Legal Name Bright Path Laboratories
- Latest Funding Round$8.46M (USD), Debt – Conventional
Nov 2021
Products & Services of Bright Path Labs
Bright Path Labs offers a comprehensive portfolio of products and services, including Manufacturing Services and Research and Development.
Offers production of safe and sustainable medicines for clients
Conducts labs for developing affordable pharmaceutical solutions
Funding Insights of Bright Path Labs
- Total Rounds 1
- Last Round Debt – Conventional — $8.46M
- First Round $8.46M
(Nov 2021)
All 1 funding rounds of Bright Path Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $8.46M | Debt – Conventional | – | – | – |
People of Bright Path Labs
10 people are tracked at Bright Path Labs (4 in leadership, 5 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Terry Novak | Chief Commerical Officer | Leadership |
Dennis Cope | VP, Engineering | Leadership |
Heather Buchanan | Director, Analytics | Leadership |
Tony Quiñones | CEO & Board Member | Leadership |
Roger Quan | Advisor | Board & advisors |
Rolando Rodriguez | Advisor | Board & advisors |
John Lalonde | Director | Board & advisors |
Xiping Su | Director | Board & advisors |
Shiraz Kotte | Director | Board & advisors |
Michael A. Gonzalez | CSO & Board Member | Team |
Complete people profiles for Bright Path Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bright Path Labs
2 dated milestones of Bright Path Labs across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Bright Path Labs is founded.
- Funding First funding round of $8.5M.
Competitors of Bright Path Labs
Bright Path Labs has 8 listed competitors in our database, 5 of them funded. They include Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unibio.dk | 2001 | Odense, Denmark | $30M | 59 | Animal feed supplements are produced using proprietary fermentation technology. | |
| univercellstech.com | 2020 | Nivelles, Belgium | – | 74 | Intensified biomanufacturing technologies for viral production are developed and manufactured. | |
| nirrin.tech | 2018 | Billerica, United States | $4.82M | 17 | Developer of sensor and integration technologies for continuous control and bioprocess automation | |
| pow.bio | 2019 | Berkeley, United States | $9.5M | – | Intelligent fermentation services for industrial and synthetic biology are provided. | |
| caladan.bio | 2023 | Brooklyn, United States | $5.11M | – | Modular bioreactors are developed for biotechnology research applications. | |
| biozeen.com | 2005 | Bengaluru, India | – | 194 | Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals. | |
| dab.bio | 2012 | Delft, Netherlands | $2.23M | – | Technology solutions for accelerated fermentation of renewable feedstocks are provided. | |
| tecnic.eu | 2011 | Girona, Spain | – | – | Bioprocess equipment is developed for cell culture and microbial applications. |
Detailed competitors of Bright Path Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bright Path Labs
The website of Bright Path Labs (brightpathlabs.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 5.7% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Bright Path Labs (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bright Path Labs
Complete news archive for Bright Path Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bright Path Labs
Bright Path Labs was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Bright Path Labs is headquartered in Santa Fe, United States. It is registered at Santa Fe, New Mexico, United States.
Bright Path Labs was founded in 2019 and is based in Santa Fe, United States. Operations focus on pharmaceutical manufacturing technology, where spinning tube-in-tube (STT) continuous-flow reactors have been developed for drug production. These reactors are applied to scale up manufacturing processes for Covid-19 therapeutics and active pharmaceutical ingredients (APIs). The domain brightpathlabs.com is utilized for online presence.
Bright Path Labs's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
Bright Path Labs offers Manufacturing Services and Research and Development.
Bright Path Labs operates through Bright Path Laboratories.